USPTO Examiner NIA ALIREZA - Art Unit 3786

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18436091APPARATUS FOR TEMPORARY MALE CONTRACEPTIONFebruary 2024October 2025Allow2010NoNo
18299555MASSAGE STONE HEATERApril 2023January 2026Abandon3310NoNo
18030916DEVICE FOR ENDOSCOPICALLY DELIVERING A THERAPEUTIC SUBSTANCEApril 2023March 2026Abandon3511NoNo
18128483Temperature Management Case Review Performance and Treatment AnalysisMarch 2023October 2025Allow3010YesNo
17904795OPENABLE MASKAugust 2022August 2025Abandon3510NoNo
17879824Personality Attachments for Communicating a MessageAugust 2022July 2025Abandon3510NoNo
17803329Conforming face shield and frame systemMay 2022March 2026Abandon4620NoNo
17684547SMART PROTECTIVE FACE MASKMarch 2022February 2023Abandon1211NoNo
17605229Medical Fixing Material with Outstanding Breathability and Ease of ApplicationOctober 2021October 2024Abandon3510NoNo
17445346STRAPLESS FACE MASKAugust 2021July 2024Abandon3520NoNo
17444144Orthotic Device for Treating Plantar FasciitisJuly 2021July 2024Abandon3520NoNo
17415596KNEE ORTHOSISJune 2021October 2024Abandon4010NoNo
17330445CONVENIENT SPORTS TAPEMay 2021July 2024Abandon3811NoNo
17236611WASHABLE AND REUSABLE FACE MASK WITH REPLACEABLE FILTERApril 2021August 2024Abandon4010NoNo
17225919FACE MASK AND FRAMEApril 2021November 2024Abandon4351YesNo
17225335FACE MASK AND FACE MASK INSERTApril 2021September 2022Abandon1720NoNo
17274664DEVICE FOR PREVENTING PRESSURE ULCERSMarch 2021June 2024Abandon3910NoNo
17080722WALKING BOOT INSERT FOR WOUND CAREOctober 2020February 2024Abandon4021YesNo
16997932ADJUSTABLE FACE MASK ASSEMBLYAugust 2020June 2022Abandon2210NoNo
16998101APPARATUS FOR HANDS FREE APPLICATION OF COMPRESSION TO A WOUND SITEAugust 2020April 2024Abandon4410NoNo
16779216PROPHYLACTIC DEVICEJanuary 2020August 2021Abandon1921YesNo
16462481TAPE PRODUCTOctober 2019November 2024Abandon6031NoNo
16495990MASK WITH MULTI-PROFILE FRAME AND CONNECTIBLE PROFILESSeptember 2019August 2023Abandon4620YesNo
16440653Sleep Apnea Device And KitJune 2019July 2019Allow100NoNo
16282557BRACE-TYPE ANTI-SNORING DEVICEFebruary 2019January 2022Abandon3510NoNo
16278981Elbow OrthosisFebruary 2019October 2021Abandon3210NoNo
16200840ARTICULATED ROD OF AN ORTHOPEDIC DEVICENovember 2018June 2021Abandon3010NoNo
16057737WELDED BACK BRACEAugust 2018May 2022Abandon4520NoNo
15977589MOUTHGUARD SYSTEMMay 2018October 2021Abandon4130YesNo
15975453Prophylactic DeviceMay 2018October 2019Abandon1800NoNo
15971926Health Care DeviceMay 2018March 2021Abandon3410NoNo
15925352PERCUTANEOUS VASCULAR INJURY TREATMENT SYSTEMS AND METHODSMarch 2018June 2022Abandon5111YesNo
15568671GUIDE JOINT FOR A JOINT ORTHOSISOctober 2017August 2020Abandon3410NoNo
15320352ORAL APPLIANCE FIXED TO LOWER TEETHJune 2017July 2020Abandon4210NoNo
15597802Intraoral Orthosis for Mandibular Advancement for Snoring and Obstructive Sleep ApneaMay 2017April 2020Abandon3510NoNo
15497345WOUND CARE PRODUCTApril 2017July 2021Abandon5121NoNo
15507682INSERT FOR HUMANS AND ANIMALS AND THE PROCESS FOR PRODUCING THE SAMEFebruary 2017September 2020Abandon4320NoNo
15504284NEUROARTHROMYOFASCIAL ENHANCEMENT WEARFebruary 2017August 2020Abandon4211NoNo
15504243IMMOBILIZATION MASKFebruary 2017April 2020Abandon3810NoNo
15425602ORTHOTIC APPLIANCE WITH CONTINUOUSLY ADJUSTABLE POSITIONING OF CORRECTIVE ELEMENTSFebruary 2017September 2021Abandon5521YesNo
15408795WOUND TREATMENT SYSTEM AND METHODJanuary 2017August 2020Abandon4321YesNo
15365067HYDRATING MOUTH GUARDNovember 2016October 2020Abandon4720NoNo
15530051Flexible nonviolent intervention shieldNovember 2016October 2020Abandon4720NoNo
15313803ORTHOPEDIC DEVICE FOR LIMITING THE MOVEMENT OF A JOINT ARRANGED BETWEEN A FIRST AND A SECOND BODY REGIONNovember 2016November 2020Abandon4810NoNo
15343567FRAGMENT SPECIFIC FRACTURE REDUCTION BRACE AND ASSOCIATED METHOD OF USENovember 2016June 2020Abandon4320NoNo
15332077HAND SUSPENSION FIXTUREOctober 2016October 2020Abandon4740YesNo
15112864Anti-Snoring DeviceJuly 2016July 2019Abandon3610NoNo
15112815SAFETY HARNESSJuly 2016June 2019Abandon3510NoNo
14980595DOUBLE SOFT COLLARDecember 2015March 2020Abandon5130YesNo
14938983MOLDABLE SPLINT AND METHOD OF USING SAMENovember 2015March 2022Abandon6041NoNo
14759993BACK SUPPORTJuly 2015January 2019Abandon4220NoNo

Appeals Overview

No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.

Examiner NIA, ALIREZA - Prosecution Strategy Guide

Executive Summary

Examiner NIA, ALIREZA works in Art Unit 3786 and has examined 43 patent applications in our dataset. With an allowance rate of 2.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 40 months.

Allowance Patterns

Examiner NIA, ALIREZA's allowance rate of 2.3% places them in the 1% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by NIA, ALIREZA receive 1.67 office actions before reaching final disposition. This places the examiner in the 34% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by NIA, ALIREZA is 40 months. This places the examiner in the 25% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a -3.0% benefit to allowance rate for applications examined by NIA, ALIREZA. This interview benefit is in the 7% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 0.0% of applications are subsequently allowed. This success rate is in the 1% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 4% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Petition Practice

When applicants file petitions regarding this examiner's actions, 28.6% are granted (fully or in part). This grant rate is in the 16% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.